Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Anophthalmia: Causes, Diagnosis, Treatment | OBN
Anophthalmia is a severe form of eye malformation in which the eye structures fail to develop properly during embryonic development. It can occur unilaterally, affecting one eye, or bilaterally, affecting both eyes. The absence of one or both eyes can…
The Link Between Cataract Surgery and Dry Eye Disease
Cataract surgery is a common procedure performed to restore vision by removing a cloudy lens and replacing it with an artificial intraocular lens. While the surgery is generally successful, some patients may experience dry eye syndrome as a potential complication.…
Bausch + Lomb Acquires Blink® Eye Drops
Bausch + Lomb announced that one of its affiliates has completed the purchase of the Blink® product line of eye and contact lens drops from Johnson & Johnson Vision. This strategic acquisition reflects the company’s commitment to enhancing over-the-counter (OTC)…
Invirsa Closes $7.7M Series B Financing
Invirsa has announced the completion of a $7.7 million Series B financing in April this year. The financing round was led by CincyTech, an Ohio-based venture firm, with participation from Rev1 Ventures, JobsOhio Growth Capital Fund, and JumpStart Ventures. The…
Oral Probiotics: A New Frontier in Dry Eye Treatment
At ASM Microbe 2023, the annual meeting of the American Society for Microbiology, a research group from Baylor College of Medicine presented their study on the potential benefits of a commercially available probiotic bacterial strain in treating dry eye disease.…
Marinomed Set to Launch Carragelose Eye Drops in 2024
Marinomed Biotech has announced the introduction of a new Carragelose eye drop product, known as MAM-1001-3, to their existing Carragelose OTC portfolio. The product has obtained certification under the Medical Device Directive (MDD) and is currently undergoing preparations for marketing.…
Cellusion Secures $21 Million Funding
Cellusion, a Tokyo-based biotech company, announced the successful completion of its Series C Round financing, raising an impressive 2.83 billion yen, equivalent to $21 million. The primary focus of this funding is to accelerate the advancement of Cellusion’s lead program,…
Hans Jürgen Thier Named as Germany CM at VSY Biotech
Andreas Kühnel, Managing Director of VSY Biotechnology, headquartered and legally based in Leinfelden-Echterdingen, announced the appointment of Hans Jürgen Thier as the new Country Manager for Germany. Kühnel announced that exports from VSY Biotechnology in Germany have substantially increased by…
New App Launched to Help Children with Amblyopia
Eye specialists, mathematicians, and game designers at the University of Southampton have collaborated to create and launch a smartphone app with the goal of enhancing crucial treatment for children diagnosed with amblyopia, a prevalent visual impairment commonly referred to as…
What is Lacrimal Lake Treatment
Let’s start with the definition of the lacrimal lake, as you may guess, the lacrimal lake is a pool of tears in the lower section of the eye that drains into the tear drainage system. Actually, we have a lacrimal…